A new daily pill could help people coming off weight-loss jabs remain slim, latest research says.
The drug is already available in the US and could soon launch in the UK.
Trials found that patients given the tablet, called orforglipron, every day for a year avoided regaining much of the weight they had lost - a known risk when coming off GLP-1 injections.
The study in the journal Nature Medicine was funded by the manufacturer Eli Lilly, which also makes the weight loss jab Mounjaro.
More research is needed to find out how long someone might need to stay on treatment - it might even be life-long, say experts.
